跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,958 条关于
“BorDex”
全部
1,958
临床试验
1,767
药物
37
机构
23
资讯
131
2年前
China Grants Breakthrough Therapy Designation to GSK's Blenrep for Multiple Myeloma
去年
Blenrep Demonstrates Overall Survival Benefit in Relapsed/Refractory Multiple Myeloma
去年
Blenrep Demonstrates Overall Survival Benefit in DREAMM-7 Trial for Relapsed/Refractory Multiple Myeloma
2年前
GSK's Blenrep Receives Breakthrough Therapy Designation in China and Japan Review for Multiple Myeloma
去年
GSK's Blenrep Demonstrates Overall Survival Benefit in DREAMM-7 Trial for Multiple Myeloma
去年
GSK's Blenrep Combo Demonstrates Superior Survival in Multiple Myeloma
2年前
Blenrep Combination Receives Breakthrough Therapy Designation in China for Multiple Myeloma
2年前
GSK's Blenrep Shows Superiority in Phase III Multiple Myeloma Trial
去年
GSK's Blenrep Secures UK Approval for Multiple Myeloma Treatment in Combination Therapy
去年
GSK's Blenrep Demonstrates Significant Survival Benefit in Multiple Myeloma Trial, Paving Way for Potential Comeback
第 1 页,共 14 页
上一页
下一页